Jun 16, 2025, 17:06
Carmen Criscitiello Highlights Strategies to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer
Carmen Criscitiello, Director of Precision Oncology Unit at IEO European Institute of Oncology, shared a post on Linkedin:
“Just published in Cancer Treatment Reviews!
We took a deep dive into one of the most pressing challenges in HR+/HER2– BC: resistance to CDK4/6i.
In this review, we explore:
Why resistance emerges
How to counter it with innovative combinations
What’s next in endocrine, targeted, and immune-based strategies
This work reflects a strong collaborative effort across leading institutions.”
Title: Overcoming resistance to CDK4/6 inhibitors in hormone receptor positive, HER2 negative breast cancer: Innovative combinations and emerging strategies
Authors: Federica Giugliano, Carmine De Angelis, Barbara Pistilli, Giulia Viale, Giampaolo Bianchini, Mario Giuliano, Luca Malorni, Beatrice Taurelli Salimbeni, Angela Esposito, Antonio Giordano, Timothy A. Yap, Giuseppe Curigliano, Carmen Criscitiello
You can read the Full Artcile on Cancer Treatment Reviews
More posts featuring Breast Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38